Live attenuated vaccine
Sponsors
Department of Nephrology and Rheumatology National Center for Child Health and Development, Department of Pediatrics, Yokohama City University, Saga University
Conditions
Patients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)collagen diseases, kidney diseases, digestive diaseases, liver diaseases, neurological diseases, kidney transplant patientstuberous sclerosis
Unknown Phase
Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants
Active, not recruitingJPRN-UMIN000007710
Start: 2012-05-01Target: 200Updated: 2026-06-29
The efficacy and safety of live attenuated vaccine in patients treated with steroid and immunosuppresive drugs: A prospective study
Active, not recruitingJPRN-UMIN000018627
Start: 2015-10-01Target: 80Updated: 2026-06-29
Multicenter prospective cohort study of vaccine safety for infants with tuberous sclerosis during evelolimus treatment
Active, not recruitingJPRN-UMIN000047238
Start: 2022-05-01Target: 60Updated: 2026-06-29